lfasalazine is used in the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease. It is also indicated for use in rheumatoid arthritis and used in other types of inflammatory arthritis (e.g. psoriatic arthritis and reactive arthritis).
It is usually not given to children under 2 years of age.
Less common side effects of sulfasalazine include:
Serious side effects of sulfasalazine include:
Postmarketing side effects of sulfasalazine reported include:
Adult and Pediatric Dosage Forms and Strengths
Tablet, enteric coated (delayed release)
Dosage Considerations – Should be Given as Follows:
Juvenile Rheumatoid Arthritis
Crohn's Disease (Off-label)
If your doctor has directed you to use this medication for your condition, your doctor or pharmacist may already be aware of any possible drug interactions or side effects and may be monitoring you for them. Do not start, stop, or change the dosage of this medicine or any medicine before getting further information from your doctor, healthcare provider or pharmacist first.
Sulfasalazine has no known severe interactions with other drugs.
Serious interactions of sulfasalazine include:
Sulfasalazine has moderate interactions with at least 215 different drugs.
Sulfasalazine has mild interactions with at least 124 different drugs.
Severe allergy or bronchial asthma.
Blood dyscrasias; serious infections reported, including fatal sepsis and pneumonia; some infections were associated with agranulocytosis, neutropenia, or myelosuppression.
This medication contains sulfasalazine. Do not take Azulfidine or Azulfidine EN if you are allergic to sulfasalazine or any ingredients contained in this drug.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center immediately.